DHCR24 Protein

DHCR24 Protein

Overview

DHCR24, officially designated 24-dehydrocholesterol reductase, is an endoplasmic reticulum-localized enzyme that catalyzes the final step of cholesterol biosynthesis. This 56 kDa protein (489 amino acids) is encoded by the DHCR24 gene located on chromosome Xp11.22 in humans. The enzyme reduces 24-dehydrocholesterol (desmosterol) to cholesterol, completing the Bloch pathway of steroid biosynthesis. DHCR24 exists in two isoforms—an S-form (sterol-sensing domain-containing) and a non-S form—both capable of catalyzing this critical reduction reaction. The protein is ubiquitously expressed across tissues, with particularly high levels in sterol-synthesizing organs including the liver, adrenal glands, and central nervous system. The broad tissue distribution reflects cholesterol's essential roles in membrane structure, myelin formation, and neuronal function.

Function and Biology

DHCR24 Protein

Overview

DHCR24, officially designated 24-dehydrocholesterol reductase, is an endoplasmic reticulum-localized enzyme that catalyzes the final step of cholesterol biosynthesis. This 56 kDa protein (489 amino acids) is encoded by the DHCR24 gene located on chromosome Xp11.22 in humans. The enzyme reduces 24-dehydrocholesterol (desmosterol) to cholesterol, completing the Bloch pathway of steroid biosynthesis. DHCR24 exists in two isoforms—an S-form (sterol-sensing domain-containing) and a non-S form—both capable of catalyzing this critical reduction reaction. The protein is ubiquitously expressed across tissues, with particularly high levels in sterol-synthesizing organs including the liver, adrenal glands, and central nervous system. The broad tissue distribution reflects cholesterol's essential roles in membrane structure, myelin formation, and neuronal function.

Function and Biology

DHCR24 functions as a Δ24-reductase enzyme within the final step of post-squalene cholesterol synthesis. The reaction catalyzed by DHCR24 converts desmosterol (24-dehydrocholesterol) to cholesterol using NADPH as a reducing agent. This enzymatic step represents one of two alternative pathways (Bloch and Kandutsch-Russell pathways) through which cells can complete cholesterol biosynthesis. The enzyme's activity is regulated by sterol levels through feedback inhibition and transcriptional control, maintaining cellular cholesterol homeostasis. DHCR24 also possesses oxysterol-binding properties that may enable its participation in lipid sensing and signaling. The protein's localization to the endoplasmic reticulum positions it optimally for integration with other sterol synthesis enzymes and for direct interaction with nascent lipoproteins. Additionally, DHCR24 has been shown to interact with cellular sterol regulatory element-binding proteins (SREBPs), linking cholesterol biosynthesis to metabolic sensing mechanisms.

Role in Neurodegeneration

DHCR24 dysfunction has emerged as a significant factor in multiple neurodegenerative conditions. The enzyme's critical importance to central nervous system physiology stems from cholesterol's essential role in myelin formation, synaptic function, and neuronal membrane integrity. Accumulated evidence indicates that reduced DHCR24 activity or genetic mutations correlate with increased neuronal vulnerability in Alzheimer's disease, Parkinson's disease, and other age-related neurodegenerative disorders. Impaired cholesterol synthesis disrupts myelin stability and axonal transport, potentially accelerating neuronal degeneration. The accumulation of desmosterol—the substrate preceding DHCR24's catalytic step—has been detected in neurodegenerative pathology and may contribute to cellular stress and proteostasis dysfunction. DHCR24 alterations also affect the production of neurosteroids, cholesterol-derived signaling molecules critical for neuroprotection and synaptic plasticity.

Molecular Mechanisms

DHCR24-related neurodegeneration involves multiple molecular pathways. Insufficient DHCR24 activity leads to altered membrane lipid composition, affecting fluidity, protein trafficking, and receptor function. This creates compensatory stress on cells, including activation of unfolded protein responses and endoplasmic reticulum stress pathways. Desmosterol accumulation itself may promote tau pathology and amyloid-beta dysfunction through altered membrane environments. DHCR24 interacts with SREBP signaling cascades, and reduced enzyme function impairs the transcriptional upregulation of cholesterol synthesis during periods of neuronal demand. The enzyme also influences oxysterol formation, with implications for liver X receptor (LXR) signaling, which regulates neuroinflammatory responses and microglial activation. Additionally, DHCR24 dysfunction correlates with mitochondrial dysfunction and increased oxidative stress, further exacerbating neuronal damage.

Clinical and Research Significance

DHCR24 genetic variations have been associated with susceptibility to Alzheimer's disease in genome-wide association studies. Reduced DHCR24 expression or activity is observed in postmortem Alzheimer's brains and correlates with disease severity. The enzyme represents a potential therapeutic target for interventions aimed at restoring neuronal cholesterol metabolism. Research indicates that maintaining optimal DHCR24 function through gene therapy or pharmacological enhancement could provide neuroprotection. Understanding DHCR24 biology also informs lipid management strategies in neurodegeneration, as cholesterol supplementation or direct metabolic pathway interventions show promise in preclinical models.

Related Entities

• DHCR7 (7-dehydrocholesterol reductase): Alternative final sterol synthesis enzyme
• SREBP proteins: Transcriptional regulators of DHCR24 expression
• Cholesterol biosynthesis pathway: Parent metabolic cascade
• LXR receptors: Oxysterol-responsive nuclear receptors
• Apolipoprotein E (APOΕ): Related cholesterol metabolism factor in neurodegeneration